| Ms Jeanne M Jahosky, LCSW | |
|
Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 | |
| (486) 823-5 | |
| Not Available |
| Full Name | Ms Jeanne M Jahosky |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | Landstuhl Regional Medical Center, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053595033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SW 6734 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jeanne M Jahosky, LCSW Unit 23152 Box 317, Apo, AE 09227 Ph: () - | Ms Jeanne M Jahosky, LCSW Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 Ph: (486) 823-5 |
News Archive
As the champagne corks are popping this New Year's Eve, the first American Baby Boomers will turn age 65. Members of the demographic bulge that transformed American politics and culture are expected to usher in yet another momentous change a huge increase in the number of Alzheimer's disease patients.
The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 - but not for those who are older, according to Mayo Clinic and Dana-Farber Cancer Institute scientists who will present their findings at the American Society of Clinical Oncology's (ASCO) annual meeting in Orlando, Fla.
Patient Access Solutions, Inc., A provider of healthcare/financial processing technologies for the healthcare and home care industry today announced that the company has reduced its outstanding liabilities by $1,768,189.00.
Today, the Biden-Harris Administration announced a $2.1 billion investment to improve infection prevention and control activities across the U.S. public health and healthcare sectors.
MedivirAB is an emerging researchbased specialty pharmaceutical company focused on infectious diseases. Medivir today announced that its investigational protease inhibitor TMC435, developed by Tibotec Pharmaceuticals, has successfully completed enrollment of three ongoing global phase 3 trials and further reports that all patients are now on TMC435 or active control treatment.
› Verified 7 days ago
Heather R Baral, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Unit 23746, Apo, AE 09034 Phone: 160-209-0423 | |
Linda Riddle, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg Unit 3215, Apo, AE 09094 Phone: 314-479-2666 | |
Mark Wesseler, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-2015 | |
Mrs. Thin Phyu Bur, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 852 Mds/sg, Unit 3503, Apo, AE 09104 Phone: 314-458-3378 | |
Andrea Lynne Galeucia, LICSW; BCD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 86 Mdg, Unit 3215, Ramstein Ab, Apo, AE 09094 Phone: 314-479-2390 | |
Tracy Cox, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Unit 33100 Box Landstuhl, Apo, AE 09180 Phone: 314-590-6310 | |
Mrs. Katheryn Rose Barry, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: Unit 3240 Box 445, Apo, AE 09094 Phone: 063-714-76951 |